A study exploring a mouse model found that edoxaban significantly inhibited the levels of inflammatory factors, upregulated the levels of chemokines, and reduced the risks of apoptosis, atrial fibrillation, and venous thrombosis by regulating the Wnt-β-mediated PI3K/AKT signaling pathway (19). Here, AKT1 is linked to atrial fibrillation.